abstract |
The present invention relates to plasminogen and plasmin variants comprising one or more point mutations in the catalytic domain that reduce or prevent autocatalytic degradation of plasmin protease activity. Also disclosed are compositions, uses, and methods of use of said variants of plasminogen and plasmin. |